Affiliation:
1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria
Abstract
Background:
Ixora coccinea is a tropical ornamental shrub employed in ethnomedicine for the
treatment of a number of diseases none of which include the Human Immunodeficiency Virus (HIV) infection.
Ixoratannin A-2, one of the constituents, was previously identified via virtual-screening and experimentally
confirmed to possess significant anti-HIV-1 activity in an in vitro CD4+ replication assay. This
activity was observed to be significantly reduced in degree in viruses lacking the protein Vpu. This suggests
the involvement of Vpu as well as other extra-Vpu macromolecules in its antiviral activity.
Methods:
In the present computational search for the identity of the other macromolecules that could possibly
explain the observed activity, a panel of fourteen established HIV-1 macromolecular targets was assembled
against which ixoratannin A-2 and other major phytoconstituents of I. coccinea were virtually
screened.
Results:
Structural analyses of the computed ligand-bound complexes, as well as the careful investigation
of the thermodynamic attributes of the predicted binding, revealed subtle selectivity patterns at the atomistic
level that suggest the likely involvement of multiple macromolecular processes. Some of the binding interactions
were found to be thermodynamically favourable, including the multidrug-resistant HIV protease
enzyme, CXCR4 and the human elongin C protein all of which formed reasonably strong interactions with
ixoratannin A-2 and other constituents of I. coccinea.
Conclusion:
Ixoratannin A-2’s ability to favourably interact with multiple HIV-1 and human targets could
explain its observed extra-Vpu antiviral activity. This, however, does not imply uncontrolled binding with
all available targets; on the other hand, molecular size of ixoratannin A-2 and combination of functional
groups confer on it a decent level of selectivity against many of the investigated HIV/AIDS targets.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,General Medicine
Reference69 articles.
1. Shafer R.W.; Schapiro J.M.; HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev 2008,10(2),67-84
2. Mugomeri E.; Chatanga P.; Chakane N.; Medicinal herbs used by HIV-positive people in Lesotho. Afr J Tradit Complement Altern Med 2016,13(4),123-131
3. Vermani K.; Garg S.; Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharmacol 2002,80(1),49-66
4. Chinsembu K.; Hedimbi M.; Ethnomedicinal plants and other natural products with anti-HIV active compounds and their putative modes of action. Int J Biotechnol Mol Biol Res 2010,1,74-91
5. In vitro screening of traditional medicines for anti-HIV Activity: memorandum from a WHO meeting. Bull World Health Organ World Health Organization1989,67,613-618
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献